Crescent Biopharma(DE:C68)
€11.80+0.40 (+3.51%)
DE:C68
Crescent Biopharma earnings date
€11.80
At close:+0.40 (+3.51%)
Crescent Biopharma (C68) Q4 2021 Earnings Report
2 Followers
DE:C68 Q4 2021 EPS Results
- Actual EPS
- -EUR 29.83
- Consensus EPS
- -EUR 30.96
- Beat/Miss
- Beat by +EUR 1.13
- One Year Ago EPS
- -EUR 28.93
DE:C68 Q4 2021 Revenue Results
- Actual Revenue
- EUR 16.27K
- Expected Revenue
- EUR 0
- Beat/Miss
- Beat by +EUR 16.27K
- YoY Revenue Growth
- -88.96%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 03/03/2022
- Time
- Before Open
- Conference Call
- Thursday, March 3, 2022
DE:C68 Upcoming Earnings
Crescent Biopharma's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:C68 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.66- | -3.62 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.63-0.81 | -1.15 | 29.13% (+0.33) | |
| Jul 30, 2026 | 2026 (Q2) | -0.67-0.67 | -4.46 | 84.99% (+3.79) | |
| Apr 29, 2026 | 2026 (Q1) | -0.79-0.63 | -16.11 | 96.07% (+15.48) | |
| Feb 26, 2026 | 2025 (Q4) | -2.23-3.62 | -7.23 | 49.88% (+3.61) | |
| Nov 06, 2025 | 2025 (Q3) | -1.77-1.15 | -325.75 | 99.65% (+324.60) | |
| Jul 31, 2025 | 2025 (Q2) | -1.51-4.46 | -14.15 | 68.51% (+9.70) | |
| May 01, 2025 | 2025 (Q1) | -0.05-0.05 | -0.15 | 70.59% (+0.11) | |
| Feb 27, 2025 | 2024 (Q4) | -0.07-0.10 | -0.13 | 20.00% (+0.03) | |
| Nov 07, 2024 | 2024 (Q3) | -0.10-0.14 | -0.13 | -8.57% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
